Ultrafast air purification using nanoparticle-enhanced UV integrating cavity technology
Novel air purification technology combining concentrated UV radiation with plasmonic nanomaterials to inactivate VOCs, odors, and airborne pathogens. Demonstrated over 2 orders of magnitude higher virus inactivation efficiency than standard UV lamps, with potential applications in indoor air quality, healthcare facilities, and commercial HVAC systems.
Overview
This technology offers a novel approach to air purification by combining concentrated ultraviolet (UV) radiation with highly reflective nanomaterials inside an integrating cavity (IC) design. The system targets volatile organic compounds (VOCs), odors, and airborne pathogens through the synergistic action of UV photochemistry, plasmonic heating, hot electron effects, and engineered radiation design. By using inexpensive commercial foil-based nanoparticles such as TiO2, Al2O3, and aluminum (Al) plasmonic materials combined with broad-spectrum UV sources including ultrafast and continuous-wave lasers and lamps, the technology aims to significantly exceed the performance of current air purification solutions. Potential applications include indoor air quality management in healthcare facilities, commercial buildings, industrial settings, and residential HVAC systems.
Technical specifications
Core technology components:
- Integrating cavity (IC) coated with highly UV-reflective PTFE material achieving 93% reflectance, enabling multi-pass UV exposure that dramatically increases inactivation efficiency
- Plasmonic nanoparticles including aluminum variants that enhance UV effects through plasmonic heating and hot electron generation
- Broad-spectrum UV sources including pulsed lasers (226 nm, 266 nm, 213 nm) and conventional UV lamps for flexible deployment
- Synergistic treatment mechanisms combining UV photochemistry, plasmonic nanoparticle effects, and optimized radiation geometry
Demonstrated performance:
- More than 2 orders of magnitude higher virus inactivation efficiency compared to standard UV lamp technology
- 3 orders of magnitude higher efficiency relative to direct UV laser exposure without the integrating cavity
- Validated against respiratory syncytial virus (RSV), HCoV-229E coronavirus, and SARS-CoV-2 using microdroplet exposure protocols
Technology readiness level
The technology has undergone laboratory validation with controlled experiments testing virus inactivation efficiency. Testing was performed with three replicates across three independent experiments, with statistical significance determined using ANOVA and Dunnett's post hoc test (p < 0.05). Pulsed UVB excimer laser control experiments at 308 nm confirmed the unique advantages of the proposed wavelength range. Future validation efforts will focus on second-generation device construction with improved reflectivity materials, systematic studies of laser pulse width effects (from nanosecond to femtosecond), wavelength optimization (266 nm and 213 nm), and molecular composition analysis for organic chemical removal. The planned 6-month validation program will establish performance parameters for VOC and odor removal applications.
About University of South Florida
A comprehensive public research university with multiple campuses across the Tampa Bay region, USF combines scale with an applied, partnership‑driven culture. A research and technology park anchors co‑located corporate R&D, startups, and shared facilities that enable prototyping and testing. USF Health’s connection to a major hospital system and nearby specialty clinics supports clinical studies, device validation, and translational collaborations. Research is supported by competitive federal funding from agencies such as NIH, NSF, and DoD. A dedicated technology transfer office and research foundation manage IP, licensing, industry agreements, and venture creation, with incubator and accelerator resources in the park.
delivered to your inbox.